EquityBulls

Latest News

Keywords Selected: Tablets

Stock Report

SMS Pharmaceutical's associate company, VKT Pharma, receives US FDA approval for its reformulated Ranitidine
Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
Marksans Pharma Inc. receives USFDA approval for Loperamide Hydrochloride Tablets USP, 2 mg (OTC).
Biocon Pharma Ltd receives approval from USFDA for its ANDA
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
Zydus receives tentative approval from USFDA for Olaparib Tablets, 100 mg and 150 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg
NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)
Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended Release Tablets USP, 25 mg and 37.5 mg.
Relonchem Limited receives Marketing Authorization for its products
ZyVet® launches affordable Furosemide tablets to support long-term heart care trusted diuretic for dogs and cats now available in a generic form
NATCO launches Bosentan Tablets for Oral Suspension in the United States with 180-day exclusivity
Lupin launches Bosentan Tablets for Oral Suspension in the United States with 180-Day Exclusivity
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg
Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
Shilpa Medicare announces the approval of Nor Ursodeoxycholic Acid Tablets 500 mg for the treatment of Non‐Alcoholic Fatty Liver Disease in India
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 & 1 mg
Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets
Lupin launches Prucalopride tablets in the United States
Lupin receives approval from U.S. FDA for Prucalopride Tablets